Cita APA (7a ed.)

C, Z., X, Z., L, L., T, M., M, S., Y, Y., & Q, F. (2019). A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. Dove Medical Press.

Cita Chicago Style (17a ed.)

C, Zhang, Zhu X, Li L, Ma T, Shi M, Yang Y, y Fan Q. A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2019.

Cita MLA (8a ed.)

C, Zhang, et al. A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3 Inflammasome Activation. Dove Medical Press, 2019.